Applied immunohistochemistry & molecular morphology : AIMM · 2026
Immunohistochemical Analysis of STAT3 and ITGB6 in Oral Squamous Cell Carcinoma: Prognostic Relevance for Lymph Node Metastasis and Overall Survival.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rajoria Shivangni, Kumar Priya, Kumar Anshuman, Aiyer Hema M, Rawat Garima, Urs Aadithya B
Аннотация
BACKGROUND: Signal transducer and activator of transcription 3 (STAT3), a transcription factor and Integrin αvβ6 (ITGB6), a transmembrane protein are upregulated in a wide array of cancers. Oral squamous cell carcinoma (OSCC) has an invasive potential and a tendency to metastasize chiefly to cervical lymph nodes ultimately affecting the survival rate. This study endeavours to determine the role and correlation of STAT3 and ITGB6 in OSCC with and without lymph node metastasis and their association with overall survival.
MATERIAL AND METHODS: A total of 100 cases of OSCC were included, comprising 50 cases with lymph node metastasis (nodal group) and 50 without nodal metastasis (non-nodal group). All cases were assessed histologically for prognostic scoring and were immunohistochemically stained using STAT3 and ITGB6 markers. Clinicopathological parameters with STAT3 and ITGB6 immunoexpressions along with overall survival with a mean follow-up period of 48 months were assessed as Immunoreactive score (IRS).
RESULTS: Significantly stronger expression (IRS 2) of STAT3 and ITGB6 was observed in OSCC cases with lymph node metastasis. The nodal group with stronger STAT3 and ITGB6 expressions showed lower survival although no statistically significant differences were found. These markers showed prognostic significance independently, but no significant correlation was observed between the 2.
CONCLUSION: On the basis of our findings, STAT3 and ITGB6 were statistically associated with lymph node metastasis. Thus, we hypothesised that their increased expression can lead to the migration of cancer cells, resulting in lymph node metastasis and affecting overall survival. Further understanding of the signalling pathways mediating STAT3 and ITGB6 may help identify valid therapeutic targets for OSCC patients.
MATERIAL AND METHODS: A total of 100 cases of OSCC were included, comprising 50 cases with lymph node metastasis (nodal group) and 50 without nodal metastasis (non-nodal group). All cases were assessed histologically for prognostic scoring and were immunohistochemically stained using STAT3 and ITGB6 markers. Clinicopathological parameters with STAT3 and ITGB6 immunoexpressions along with overall survival with a mean follow-up period of 48 months were assessed as Immunoreactive score (IRS).
RESULTS: Significantly stronger expression (IRS 2) of STAT3 and ITGB6 was observed in OSCC cases with lymph node metastasis. The nodal group with stronger STAT3 and ITGB6 expressions showed lower survival although no statistically significant differences were found. These markers showed prognostic significance independently, but no significant correlation was observed between the 2.
CONCLUSION: On the basis of our findings, STAT3 and ITGB6 were statistically associated with lymph node metastasis. Thus, we hypothesised that their increased expression can lead to the migration of cancer cells, resulting in lymph node metastasis and affecting overall survival. Further understanding of the signalling pathways mediating STAT3 and ITGB6 may help identify valid therapeutic targets for OSCC patients.